This is Welldoc’s 8th 510(k) filing to the U.S. Food and Drug Administration Columbia, MD – January 16, 2020 – Welldoc, a leading digital health company, announced today the filing…
Read ArticleFuture-focused formulary for digital health, medicine and therapeutics will allow employers and health plans to effectively manage a fast-growing segment of health care while improving access for patients. ST. LOUIS,…
Read ArticleDevelop and commercialize digital health solutions globally for multiple therapeutic areas, including in Japan for diabetes patients TOKYO and Columbia, Maryland, November 20, 2019 – Astellas Pharma Inc. (TSE: 4503,…
Read ArticleThis is the 7th FDA 510(k) clearance for BlueStar, which was initially cleared for adults with type 2 diabetes Columbia, MD – November 5, 2019 – Welldoc, a leading digital…
Read ArticleBlueStar Will Now Be Available to 400,000+ Employees with Type 2 Diabetes through Competitive Health’s SHOWBenefits Platform Irvine, CA and Columbia, MD – October 29, 2019 – Competitive Health and Welldoc…
Read ArticleThe collaboration seeks to support self-insured employers to help their employees and dependents with type 2 diabetes better manage their condition MALVERN, Pa., (October 1, 2019) – LifeScan, a world…
Read ArticleColumbia, Maryland, September 24, 2019 – Welldoc®, a leading digital health company, announced today that its executives and digital health, diabetes and healthcare industry thought leaders will speak and/or participate in…
Read Article